‘Surprising’ finding by Australian-led study is first recorded instance of one antibiotic causing resistance to another in a different class
The rise of an almost untreatable superbug has been linked to a common antibiotic, an Australian-led study has found.
The study – published in Nature – found that rifaximin, an antibiotic used to treat liver disease, causes resistance to another antibiotic, daptomycin.
More Stories
Sweden warns of heightened risk of Russian sabotage
NHS in England to trial AI tool to predict risk of fatal heart disease
Tesla shares jump in third quarter earnings even as expected revenue is lower